Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Functional ABCG1 expression induces apoptosis in macrophages and other cell types.

Seres L, Cserepes J, Elkind NB, Törocsik D, Nagy L, Sarkadi B, Homolya L.

Biochim Biophys Acta. 2008 Oct;1778(10):2378-87. doi: 10.1016/j.bbamem.2008.06.010. Epub 2008 Jun 19.

2.

Combined localization and real-time functional studies using a GFP-tagged ABCG2 multidrug transporter.

Orbán TI, Seres L, Ozvegy-Laczka C, Elkind NB, Sarkadi B, Homolya L.

Biochem Biophys Res Commun. 2008 Mar 14;367(3):667-73. doi: 10.1016/j.bbrc.2007.12.172. Epub 2008 Jan 7.

PMID:
18182157
3.

Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, Koblos G, Elkind NB, Ward Y, Dean M, Sarkadi B, Bates SE.

Biochemistry. 2006 Apr 25;45(16):5251-60.

4.

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters.

Ozvegy-Laczka C, Cserepes J, Elkind NB, Sarkadi B.

Drug Resist Updat. 2005 Feb-Apr;8(1-2):15-26. Review.

PMID:
15939339
5.

Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

Elkind NB, Szentpétery Z, Apáti A, Ozvegy-Laczka C, Várady G, Ujhelly O, Szabó K, Homolya L, Váradi A, Buday L, Kéri G, Német K, Sarkadi B.

Cancer Res. 2005 Mar 1;65(5):1770-7.

6.

Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization.

Cserepes J, Szentpétery Z, Seres L, Ozvegy-Laczka C, Langmann T, Schmitz G, Glavinas H, Klein I, Homolya L, Váradi A, Sarkadi B, Elkind NB.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):860-7.

PMID:
15240127
7.

The C-terminal tail of the metabotropic glutamate receptor subtype 7 is necessary but not sufficient for cell surface delivery and polarized targeting in neurons and epithelia.

McCarthy JB, Lim ST, Elkind NB, Trimmer JS, Duvoisin RM, Rodriguez-Boulan E, Caplan MJ.

J Biol Chem. 2001 Mar 23;276(12):9133-40. Epub 2000 Dec 5.

8.

Role of actin and Myo2p in polarized secretion and growth of Saccharomyces cerevisiae.

Karpova TS, Reck-Peterson SL, Elkind NB, Mooseker MS, Novick PJ, Cooper JA.

Mol Biol Cell. 2000 May;11(5):1727-37.

9.

The role of the COOH terminus of Sec2p in the transport of post-Golgi vesicles.

Elkind NB, Walch-Solimena C, Novick PJ.

J Cell Biol. 2000 Apr 3;149(1):95-110.

10.
11.

The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells.

Peled A, Schwartz D, Elkind NB, Wolkowicz R, Li R, Rotter V.

Oncogene. 1996 Oct 17;13(8):1677-85.

PMID:
8895513
12.

Spot-1, a novel NLS-binding protein that interacts with p53 through a domain encoded by p(CA)n repeats.

Elkind NB, Goldfinger N, Rotter V.

Oncogene. 1995 Sep 7;11(5):841-51.

PMID:
7675445
14.

The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.

Wolkowicz R, Elkind NB, Ronen D, Rotter V.

Oncogene. 1995 Mar 16;10(6):1167-74.

PMID:
7535417
15.

Does wild-type p53 play a role in normal cell differentiation?

Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Simons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A, Goldfinger N.

Semin Cancer Biol. 1994 Jun;5(3):229-36. Review.

PMID:
7948951
16.

c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

Reisman D, Elkind NB, Roy B, Beamon J, Rotter V.

Cell Growth Differ. 1993 Feb;4(2):57-65.

Supplemental Content

Loading ...
Support Center